News

Immunotherapy induces ‘striking’ responses in non–small cell lung cancer

Publish date: October 9, 2013

 

AT THE EUROPEAN CANCER CONGRESS 2013

Genentech, a member of the Roche Group, supported the study. Dr. Soria received research funding and advised the company. Dr. Baas received research grants from Pfizer and Roche and advised MSD and Verastem.

Pages

Recommended Reading

Start sleep apnea therapy with CPAP, not surgery
MDedge Internal Medicine
Obstructive sleep apnea is a risk factor for Barrett’s esophagus
MDedge Internal Medicine
Limited data support multiple myositis treatment options
MDedge Internal Medicine
Flu outlook 2013-2014: Don’t hesitate. Vaccinate!
MDedge Internal Medicine
Autoantibodies play role in myositis classification, treatment
MDedge Internal Medicine
Stereotactic radiotherapy cost effective for early NSCLC
MDedge Internal Medicine
Vaccine extended overall survival in subset of NSCLC patients
MDedge Internal Medicine
Four-variable score predicts acute kidney injury
MDedge Internal Medicine
Antibiotics are overprescribed for sore throat, bronchitis
MDedge Internal Medicine
Novel oral vasodilator approved to treat pulmonary hypertension
MDedge Internal Medicine